Consensus Novavax, Inc.

Equities

NVAX

US6700024010

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
15.5 ^USD	+2.31%		+19.14%	+222.92%

May. 24	Novavax awaits FDA decision on whether its next COVID shot can be offered in US	RE
May. 23	Novavax, Inc. Notifies Retirement of Filip Dubovsky as President, Research and Development, Effective as of June 30, 2024	CI

Evolution of the average Target Price on Novavax, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e6944.hJrNMGfK2TwNGZFaiSwHB098fwYpMKWtQDra8RdavZc.1NePCVX5nl5AXcI13kliMy07CWhLReObBlSdllg03vmy0aBoNIi2Wmwv9g~b00520670a5152783e326032fe3a18d2

Analyst Recommendations on Novavax, Inc.

B. Riley Boosts Price Target on Novavax to $29 From $11, Maintains Buy Rating	May. 23	MT
Novavax Stockholder Shah Capital Withdraws Campaign Against Reelection of Directors	May. 20	MT
Shah Capital withdraws campaign against three Novavax directors	May. 20	RE
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Tuesday; AMC Entertainment, GameStop to Advance	May. 14	MT
Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi	May. 10	MT
HEDGE FUND SHAH CAPITAL SAYS NOVAVAX-SANOFI DEAL IS "A STEP IN T…	May. 10	RE
HEDGE FUND SHAH CAPITAL - NOVAVAX-SANOFI DEAL CONCURS WITH SHAH…	May. 10	RE
Novavax's Shareholder Shah Capital Urges Vote Against Re-Election of Directors	May. 06	MT
Novavax's top shareholder Shah Capital ramps up efforts for board shakeup	May. 06	RE
Shah Capital urges Novavax shareholders to vote against three directors	May. 06	RE
Novavax investor Shah Capital to vote against three directors	May. 06	RE
Novavax Shareholder Shah Capital Pushes to Add 2 Nominees to Company's Board	Apr. 15	MT
Hedge fund Shah Capital urges Novavax board shake-up, FT says	Apr. 15	RE
Hedge fund Shah Capital urges board shake-up at Novavax over struggling Covid vaccine, FT reports	Apr. 15	RE
HC Wainwright Cuts Price Target on Novavax to $19 From $35, Keeps Buy Rating	Mar. 01	MT
B. Riley Trims Novavax's PT to $11 From $12 After Reaching Settlement on Gavi Arbitration Dispute, Keeps Buy Rating	Feb. 23	MT
WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge	Jan. 12	RE
Novavax: green light for updated Covid vaccine in Sweden	Dec. 14	CF
Job losses delight investors	Dec. 06
B. Riley Lowers Novavax's Price Target to $12 From $15 After Near-Term COVID-19 Sales Estimate Revisions, Maintains Buy Rating	Nov. 10	MT
Wall Street ends lower on healthcare losses, interest rate jitters	23-08-17	RE
B. Riley Upgrades Novavax to Buy From Neutral After Above-Consensus Q2 Beat, Says Turnaround Progressing; Retains $15 PT	23-08-09	MT
US govt tells vaccine makers to price updated COVID shots reasonably	23-07-13	RE
Will the Fed follow Australia's decision to hike rates?	23-06-06
B. Riley Raises Novavax's PT to $15 From $10, Says Q1 Financial Update 'Not As Bad As Feared'; Keeps Neutral Rating	23-05-10	MT